SCOPE HEALTH 2026-05-06 Health serious FDA
Health · FDA · Recall #FDA-D-0499-2026
Optase Dry Eye Intense Drops (Glycerin 0.2%), packaged in 0.33 fl oz, Sterile,… Recall
Issued May 6, 2026 · SCOPE HEALTH
In May 2026, SCOPE HEALTH recalled the Optase Dry Eye Intense Drops (Glycerin 0.2%), packaged in 0.33 fl oz, Sterile,…, a serious health recall reported by the FDA.
Compiled by Maya Ellison, RecallCheckr
What this means for you
Lack of Assurance of Sterility
What you should do
- 1 Stop using Optase Dry Eye Intense Drops (Glycerin 0.2%), packaged in 0.33 fl oz, Sterile,… right away.
- 2 Set it aside where it won't be used by mistake.
- 3 Contact SCOPE HEALTH to arrange your voluntary. See the official notice below for contact details.
- 4 Keep the product until your remedy is fully processed. You may need it.
Official remedy (Voluntary):
Recall details
- Brand
- SCOPE HEALTH
- Category
- Health
- Recall date
- May 6, 2026
- Units affected
- Not reported
- Sold at
- Nationwide within the United States
- Recall number
- FDA-D-0499-2026
- Made in
- United States
- Issuing agency
- FDA
In context
- SCOPE HEALTH has 1 recall in our database.
- We're tracking 3,576 Health recalls in our database.
- This is the 356th Health recall we've logged in 2026.